Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting
This trial is active, not recruiting.
|Conditions||influenza-like illness, influenzal acute respiratory infection|
|Start date||February 2012|
|End date||December 2013|
|Trial size||300 participants|
|Trial identifier||NCT01687816, S53729|
This is a prospective specimen collection study targeting patients presenting with Influenza Like Illness (ILI) and/or Acute Respiratory Infection (ARI) in an out-patient setting. A non-invasive, user friendly sampling technique, using midturbinate flocked swabs will be used. These nasal swabs will be collected in different volumes of viral transport media (0.5mL and 3.0mL), for different dilution range of the viruses present in the collected biological specimen. The collection of nasal swabs samples will support the optimization of point of care detection methods for respiratory viruses responsible for ILI and/or ARI.
Only a nasal swab is collected, no therapeutic interventions
Nasal swab collection of left and right nostril
time frame: 1 day
Completion of questionnaire
time frame: 1 day
Male or female participants of any age.
Inclusion Criteria: - Male or Female - All Ages - Valid Informed Consent and/or Assent, where applicable - Onset of ILI and/or ARI within the last 3 days (≤ 72h) - Patient presented with ILI and/or ARI Exclusion Criteria: - Invalid Informed Consent and/or Assent - Onset of ILI and/or ARI was > 3 days (> 72 h) - Patient did not presented with neither ILI or ARI - Patient received intranasal attenuated influenza virus in last 3 weeks (example FluMist®, Fluenz®) - Patient received treatment with influenza direct antivirals in the last 7 days
|Official title||Prospective, Nasal Specimen Collection Study in Patients Presenting With Influenza Like Illness and/or Acute Respiratory Infection in an Outpatient Setting|
|Principal investigator||Marc Van Ranst, M.D., PhD|
Call for more information